These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9745288)

  • 1. [Case of osteomalacia due to intravenous saccharated ferric oxide].
    Nakaoka T; Sugimoto T; Okimura Y; Chihara K
    Nihon Naika Gakkai Zasshi; 1998 Jul; 87(7):1372-3. PubMed ID: 9745288
    [No Abstract]   [Full Text] [Related]  

  • 2. [2 cases of nonspecific multiple ulcers of the small intestine associated with osteomalacia caused by long-term intravenous administration of saccharated ferric oxide].
    Okada M; Imamura K; Fuchigami T; Omae T; Iida M; Nanishi F; Murakami M; Ohgushi H; Yao T; Fujita K; Ogawa K
    Nihon Naika Gakkai Zasshi; 1982 Nov; 71(11):1566-72. PubMed ID: 7166673
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia.
    Shimizu Y; Tada Y; Yamauchi M; Okamoto T; Suzuki H; Ito N; Fukumoto S; Sugimoto T; Fujita T
    Bone; 2009 Oct; 45(4):814-6. PubMed ID: 19555782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide.
    Yamamoto S; Okada Y; Mori H; Fukumoto S; Tanaka Y
    Intern Med; 2012; 51(17):2375-8. PubMed ID: 22975552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Case report; A case of FGF23-related hypophosphatemic osteomalacia caused by long-term administration of saccharated ferric oxide].
    Wada Y; Kinoshita Y; Taguchi M; Fukumoto S; Fujita T
    Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):3031-3. PubMed ID: 22175146
    [No Abstract]   [Full Text] [Related]  

  • 6. Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules.
    Sato K; Nohtomi K; Demura H; Takeuchi A; Kobayashi T; Kazama J; Ozawa H
    Bone; 1997 Jul; 21(1):57-64. PubMed ID: 9213008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iatrogenic osteomalacia caused by intravenous administration of saccharated ferric oxide.
    Suzuki A; Ohoike H; Matsuoka Y; Irimajiri S
    Am J Hematol; 1993 May; 43(1):75-6. PubMed ID: 8317471
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of osteomalacia due to deranged mineral balance caused by saccharated ferric oxide and short-bowel syndrome: A case report.
    Nomoto H; Miyoshi H; Nakamura A; Nagai S; Kitao N; Shimizu C; Atsumi T
    Medicine (Baltimore); 2017 Sep; 96(39):e8147. PubMed ID: 28953654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-induced osteomalacia].
    D'Erasmo E; Ragno A; Raejntroph N; Pisani D
    Recenti Prog Med; 1998 Oct; 89(10):529-33. PubMed ID: 9842257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saccharated ferric oxide-induced osteomalacia in Japan: iron-induced osteopathy due to nephropathy.
    Sato K; Shiraki M
    Endocr J; 1998 Aug; 45(4):431-9. PubMed ID: 9881891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia.
    Schouten BJ; Doogue MP; Soule SG; Hunt PJ
    Ann Clin Biochem; 2009 Mar; 46(Pt 2):167-9. PubMed ID: 19151167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteomalacia as a Complication of Intravenous Iron Infusion: A Systematic Review of Case Reports.
    Vilaca T; Velmurugan N; Smith C; Abrahamsen B; Eastell R
    J Bone Miner Res; 2022 Jun; 37(6):1188-1199. PubMed ID: 35426179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of hypophosphatemia induced by intravenous administration of saccharated iron oxide].
    Konjiki O; Fukaya S; Kanou H; Imamura T; Iwamoto T; Takasaki M
    Nihon Ronen Igakkai Zasshi; 1994 Oct; 31(10):805-10. PubMed ID: 7853746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-induced osteomalacia].
    Sato K
    Clin Calcium; 2007 Oct; 17(10):1536-42. PubMed ID: 17906405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iatrogenic osteomalacia: report of two cases.
    Yamamoto S; Okada Y; Mori H; Kurozumi A; Torimoto K; Arao T; Tanaka Y
    J UOEH; 2013 Mar; 35(1):25-31. PubMed ID: 23475021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment with intravenous iron and ferritin level].
    Fernández-Gallego J; Martín MA; Sujan S; Vega E
    Nefrologia; 2010; 30(3):371-2. PubMed ID: 20514109
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood and Bone Loser.
    Schaefer B; Glodny B; Zoller H
    Gastroenterology; 2017 May; 152(6):e5-e6. PubMed ID: 28384445
    [No Abstract]   [Full Text] [Related]  

  • 18. Achieving optimal patient outcomes with intravenous iron.
    Colfer M
    Nephrol Nurs J; 2003 Aug; 30(4):449-53; quiz 454-5. PubMed ID: 14533524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Osteomalacy induced by anticonvulsants. One case with a study of vitamin D metabolism].
    Lemaire V; Miravet L; Bordier P; Ryckewaert A
    Nouv Presse Med; 1975 Dec; 4(44):3121-4. PubMed ID: 1219619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery vasospasm with iron sucrose.
    George P; Das J; Pawar B; Itty C
    Nephrol Dial Transplant; 2007 Jun; 22(6):1795-6. PubMed ID: 17327282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.